Advances in the treatment for haematological malignancies

Author： Piccaluga Pier Paolo   Martinelli Giovanni   Baccarani Michele  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.6, 2006-04, pp. : 721-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Arsenic trioxide in the treatment of haematological malignancies

By Kwong Yok-Lam  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite

Nucleoside analogues in the treatment of haematological malignancies

By Johnson Stephen A  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 929-943

Informa Healthcare

Access to resources Recommend Favorite

Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly

By  

Current Pharmaceutical Design, Vol. 16, Iss. 26, 2010-09 ,pp. : 2872-2879

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?

By  

Current Medicinal Chemistry, Vol. 23, Iss. 22, 2016-07 ,pp. : 2350-2362

Bentham Science Publishers

Access to resources Recommend Favorite

The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2100-2110

Bentham Science Publishers

Access to resources Recommend Favorite